ERLIN2 and breast carcinoma: Moreover, ERLIN2 activates sterol regulatory element-binding protein 1c, which maintains high intracellular lipid expression, allowing tumorigenesis to gain a growth advantage [15], including breast cancer [16] and lung adenocarcinomas [17].